-
1
-
-
33644648880
-
Testicular germ-cell cancer
-
DOI 10.1016/S0140-6736(06)68305-0, PII S0140673606683050
-
Horwich A, Shipley J, Huddart R: Testicular germ-cell cancer. Lancet 367:754-765, 2006 (Pubitemid 43326294)
-
(2006)
Lancet
, vol.367
, Issue.9512
, pp. 754-765
-
-
Horwich, A.1
Shipley, J.2
Huddart, R.3
-
2
-
-
0036901245
-
Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: The experience of the Spanish Germ-Cell Cancer Group (GG)
-
discussion 562-563
-
Germà-Lluch JR, Garcia del Muro X, Maroto P, et al: Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis: The experience of the Spanish Germ-Cell Cancer Group (GG). Eur Urol 42:553-562, 2002; discussion 562-563
-
(2002)
Eur Urol
, vol.42
, pp. 553-562
-
-
Germà-Lluch, J.R.1
Garcia Del Muro, X.2
Maroto, P.3
-
3
-
-
65549112965
-
Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: The SWENOTECA management program
-
Tandstad T, Dahl O, Cohn-Cedermark G, et al: Risk-adapted treatment in clinical stage I nonseminomatous germ cell testicular cancer: The SWENOTECA management program. J Clin Oncol 27:2122-2128, 2009
-
(2009)
J Clin Oncol
, vol.27
, pp. 2122-2128
-
-
Tandstad, T.1
Dahl, O.2
Cohn-Cedermark, G.3
-
4
-
-
77956104590
-
Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy: A SWENOTECA study
-
Tandstad T, Cohn-Cedermark G, Dahl O, et al: Long-term follow-up after risk-adapted treatment in clinical stage 1 (CS1) nonseminomatous germ-cell testicular cancer (NSGCT) implementing adjuvant CVB chemotherapy: A SWENOTECA study. Ann Oncol 21:1858-1863, 2010
-
(2010)
Ann Oncol
, vol.21
, pp. 1858-1863
-
-
Tandstad, T.1
Cohn-Cedermark, G.2
Dahl, O.3
-
5
-
-
77950520628
-
Individualized intensification of treatment based on tumor marker decline in metastatic nonseminomatous germ cell testicular cancer (NSGCT): A report from the Swedish Norwegian Testicular Cancer Group, SWENOTECA
-
suppl; abstr 5015
-
Olofsson S, Dahl O, Jerkeman M, et al: Individualized intensification of treatment based on tumor marker decline in metastatic nonseminomatous germ cell testicular cancer (NSGCT): A report from the Swedish Norwegian Testicular Cancer Group, SWENOTECA. J Clin Oncol 27:15s, 2009 (suppl; abstr 5015)
-
(2009)
J Clin Oncol
, vol.27
-
-
Olofsson, S.1
Dahl, O.2
Jerkeman, M.3
-
6
-
-
0019523425
-
Non-seminoma germ cell tumours (malignant teratoma) of the testis. Results of treatment and an analysis of prognostic factors
-
Peckham MJ, Barrett A, McElwain TJ, et al: Non-seminoma germ cell tumours (malignant teratoma) of the testis: Results of treatment and an analysis of prognostic factors. Br J Urol 53:162-172, 1981 (Pubitemid 11116621)
-
(1981)
British Journal of Urology
, vol.53
, Issue.2
, pp. 162-172
-
-
Peckham, M.J.1
Barrett, A.2
McElwain, T.J.3
-
7
-
-
0031037241
-
International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers - International Germ Cell Cancer Collaborative Group
-
International Germ Cell Consensus Classification: A prognostic factor-based staging system for metastatic germ cell cancers - International Germ Cell Cancer Collaborative Group. J Clin Oncol 15: 594-603, 1997
-
(1997)
J Clin Oncol
, vol.15
, pp. 594-603
-
-
-
8
-
-
0026523482
-
Surveillance following orchidectomy for stage I testicular seminoma
-
Horwich A, Alsanjari N, A'Hern R, et al: Surveillance following orchidectomy for stage I testicular seminoma. Br J Cancer 65:775-778, 1992
-
(1992)
Br J Cancer
, vol.65
, pp. 775-778
-
-
Horwich, A.1
Alsanjari, N.2
A'Hern, R.3
-
9
-
-
0027362639
-
Surveillance following orchidectomy for stage I seminoma of the testis
-
von der Maase H, Specht L, Jacobsen GK, et al: Surveillance following orchidectomy for stage I seminoma of the testis. Eur J Cancer 29A:1931-1934, 1993
-
(1993)
Eur J Cancer
, vol.29 A
, pp. 1931-1934
-
-
Von Der Maase, H.1
Specht, L.2
Jacobsen, G.K.3
-
10
-
-
0028198505
-
Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: Should it be tested in a randomized trial against radiotherapy?
-
Oliver RT, Edmonds PM, Ong JY, et al: Pilot studies of 2 and 1 course carboplatin as adjuvant for stage I seminoma: Should it be tested in a randomized trial against radiotherapy? Int J Radiat Oncol Biol Phys 29:3-8, 1994
-
(1994)
Int J Radiat Oncol Biol Phys
, vol.29
, pp. 3-8
-
-
Oliver, R.T.1
Edmonds, P.M.2
Ong, J.Y.3
-
11
-
-
22544476802
-
Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: A randomised trial
-
DOI 10.1016/S0140-6736(05)66984-X, PII S014067360566984X
-
Oliver RT, Mason MD, Mead GM, et al: Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: A randomised trial. Lancet 366:293-300, 2005 (Pubitemid 41019418)
-
(2005)
Lancet
, vol.366
, Issue.9482
, pp. 293-300
-
-
Oliver, R.T.D.1
Mason, M.D.2
Mead, G.M.3
Von, D.M.H.4
Rustin, G.J.S.5
Joffe, J.K.6
De, W.R.7
Aass, N.8
Graham, J.D.9
Coleman, R.10
Kirk, S.J.11
Stenning, S.P.12
-
12
-
-
0021919904
-
Prognostic factors in advanced nonseminomatous germ-cell testicular tumours: Results of a multicentre study - Report from the Medical Research Council Working Party on Testicular Tumours
-
Prognostic factors in advanced nonseminomatous germ-cell testicular tumours: Results of a multicentre study - Report from the Medical Research Council Working Party on Testicular Tumours. Lancet 1:8-11, 1985
-
(1985)
Lancet
, vol.1
, pp. 8-11
-
-
-
13
-
-
1842509872
-
18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: An update of the prospective multicentric SEMPET trial
-
DOI 10.1200/JCO.2004.07.188
-
De Santis M, Becherer A, Bokemeyer C, et al: 2-18fluoro-deoxy-D-glucose positron emission tomography is a reliable predictor for viable tumor in postchemotherapy seminoma: An update of the prospective multicentric SEMPET trial. J Clin Oncol 22:1034-1039, 2004 (Pubitemid 41095035)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.6
, pp. 1034-1039
-
-
De, S.M.1
Becherer, A.2
Bokemeyer, C.3
Stoiber, F.4
Oechsle, K.5
Sellner, F.6
Lang, A.7
Kletter, K.8
Dohmen, B.M.9
Dittrich, C.10
Pont, J.11
-
14
-
-
34249942379
-
Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system
-
DOI 10.1200/JCO.2006.10.3523
-
Hudis CA, Barlow WE, Costantino JP, et al: Proposal for standardized definitions for efficacy end points in adjuvant breast cancer trials: The STEEP system. J Clin Oncol 25:2127-2132, 2007 (Pubitemid 46972801)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.15
, pp. 2127-2132
-
-
Hudis, C.A.1
Barlow, W.E.2
Costantino, J.P.3
Gray, R.J.4
Pritchard, K.I.5
Chapman, J.-A.W.6
Sparano, J.A.7
Hunsberger, S.8
Enos, R.A.9
Gelber, R.D.10
Zujewski, J.A.11
-
16
-
-
0037112184
-
Prognostic factors for relapse in stage I seminoma managed by surveillance: A pooled analysis
-
DOI 10.1200/JCO.2002.01.038
-
Warde P, Specht L, Horwich A, et al: Prognostic factors for relapse in stage I seminoma managed by surveillance: A pooled analysis. J Clin Oncol 20:4448-4452, 2002 (Pubitemid 35334756)
-
(2002)
Journal of Clinical Oncology
, vol.20
, Issue.22
, pp. 4448-4452
-
-
Warde, P.1
Specht, L.2
Horwich, A.3
Oliver, T.4
Panzarella, T.5
Gospodarowicz, M.6
Von, D.M.H.7
-
17
-
-
79952082270
-
Prognostic factors for relapse in stage I seminoma managed with surveillance: A validation study
-
suppl; abstr 4535
-
Chung PW, Daugaard G, Tyldesley S, et al: Prognostic factors for relapse in stage I seminoma managed with surveillance: A validation study. J Clin Oncol 28:15s, 2010 (suppl; abstr 4535)
-
(2010)
J Clin Oncol
, vol.28
-
-
Chung, P.W.1
Daugaard, G.2
Tyldesley, S.3
-
18
-
-
73149105939
-
Management of stage I seminomatous testicular cancer: A systematic review
-
Chung P, Mayhew LA, Warde P, et al: Management of stage I seminomatous testicular cancer: A systematic review. Clin Oncol (R Coll Radiol) 22:6-16, 2010
-
(2010)
Clin Oncol (R Coll Radiol)
, vol.22
, pp. 6-16
-
-
Chung, P.1
Mayhew, L.A.2
Warde, P.3
-
19
-
-
0027535136
-
Second cancer risk following testicular cancer: A follow-up study of 1,909 patients
-
van Leeuwen FE, Stiggelbout AM, van den Belt-Dusebout AW, et al: Second cancer risk following testicular cancer: A follow-up study of 1,909 patients. J Clin Oncol 11:415-424, 1993 (Pubitemid 23071036)
-
(1993)
Journal of Clinical Oncology
, vol.11
, Issue.3
, pp. 415-424
-
-
Van, L.F.E.1
Stiggelbout, A.M.2
Van, D.B.-D.A.W.3
Noyon, R.4
Eliel, M.R.5
Van, K.E.H.M.6
Delemarre, J.F.M.7
Somers, R.8
-
20
-
-
1442332185
-
Mortality after cure of testicular seminoma
-
DOI 10.1200/JCO.2004.05.205
-
Zagars GK, Ballo MT, Lee AK, et al: Mortality after cure of testicular seminoma. J Clin Oncol 22:640-647, 2004 (Pubitemid 41095067)
-
(2004)
Journal of Clinical Oncology
, vol.22
, Issue.4
, pp. 640-647
-
-
Zagars, G.K.1
Ballo, M.T.2
Lee, A.K.3
Strom, S.S.4
-
21
-
-
79952087927
-
Risk of second cancers among a cohort of 2,703 longterm survivors of testicular seminoma treated with radiotherapy
-
suppl; abstr 4538
-
Horwich A, Fossa SD, Stenning SP, et al: Risk of second cancers among a cohort of 2,703 longterm survivors of testicular seminoma treated with radiotherapy. J Clin Oncol 28:15s, 2010 (suppl; abstr 4538)
-
(2010)
J Clin Oncol
, vol.28
-
-
Horwich, A.1
Fossa, S.D.2
Stenning, S.P.3
-
22
-
-
33644660123
-
Risk-adapted management for patients with clinical stage I seminoma: The second Spanish Germ Cell Cancer Cooperative Group study
-
DOI 10.1200/JCO.2005.01.9810
-
Aparicio J, Germà JR, García del Muro X, et al: Risk-adapted management for patients with clinical stage I seminoma: The Second Spanish Germ Cell Cancer Cooperative Group study. J Clin Oncol 23: 8717-8723, 2005 (Pubitemid 46211516)
-
(2005)
Journal of Clinical Oncology
, vol.23
, Issue.34
, pp. 8717-8723
-
-
Aparicio, J.1
Germa, J.R.2
Del, M.X.G.3
Maroto, P.4
Arranz, J.A.5
Saenz, A.6
Barnadas, A.7
Dorca, J.8
Guma, J.9
Olmos, D.10
Bastus, R.11
Carles, J.12
Almenar, D.13
Sanchez, M.14
Paz-Ares, L.15
Satrustegui, J.J.16
Mellado, B.17
Balil, A.18
Lopez-Brea, M.19
Sanchez, A.20
more..
-
23
-
-
36549007486
-
Computed tomography - An increasing source of radiation exposure
-
DOI 10.1056/NEJMra072149
-
Brenner DJ, Hall EJ: Computed tomography: An increasing source of radiation exposure. N Engl J Med 357:2277-2284, 2007 (Pubitemid 350190758)
-
(2007)
New England Journal of Medicine
, vol.357
, Issue.22
, pp. 2277-2284
-
-
Brenner, D.J.1
Hall, E.J.2
-
24
-
-
58149199525
-
Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography
-
discussion 632-633
-
Tarin TV, Sonn G, Shinghal R: Estimating the risk of cancer associated with imaging related radiation during surveillance for stage I testicular cancer using computerized tomography. J Urol 181:627-632, 2009; discussion 632-633
-
(2009)
J Urol
, vol.181
, pp. 627-632
-
-
Tarin, T.V.1
Sonn, G.2
Shinghal, R.3
-
25
-
-
0037445189
-
Radiotherapy for stages IIA/B testicular seminoma: Final report of a prospective multicenter clinical trial
-
DOI 10.1200/JCO.2003.06.065
-
Classen J, Schmidberger H, Meisner C, et al: Radiotherapy for stages IIA/B testicular seminoma: Final report of a prospective multicenter clinical trial. J Clin Oncol 21:1101-1106, 2003 (Pubitemid 46594140)
-
(2003)
Journal of Clinical Oncology
, vol.21
, Issue.6
, pp. 1101-1106
-
-
Classen, J.1
Schmidberger, H.2
Meisner, C.3
Souchon, R.4
Sautter-Bihl, M.-L.5
Sauer, R.6
Weinknecht, S.7
Kohrmann, K.-U.8
Bamberg, M.9
-
26
-
-
56749175245
-
Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: A Spanish Germ Cell Cancer Group Study
-
Garcia-del-Muro X, Maroto P, Gumà J, et al: Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: A Spanish Germ Cell Cancer Group Study. J Clin Oncol 26:5416-5421, 2008
-
(2008)
J Clin Oncol
, vol.26
, pp. 5416-5421
-
-
Garcia-del-Muro, X.1
Maroto, P.2
Gumà, J.3
-
27
-
-
79952095565
-
Evolution in management of testicular seminoma: Population-based outcomes with selective utilization of active therapies
-
abstr 267
-
Kollmannsberger C, Tyldesley S, Moore C, et al: Evolution in management of testicular seminoma: Population-based outcomes with selective utilization of active therapies. Genitourinary Cancers Symposium, San Francisco, CA, March 5-7 2010 (abstr 267)
-
Genitourinary Cancers Symposium, San Francisco, CA, March 5-7 2010
-
-
Kollmannsberger, C.1
Tyldesley, S.2
Moore, C.3
|